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The data in this article is related to the research article entitled “Notch2
signaling promotes osteoclast resorption via activation of PYK2” (Jin
et al., 2016 [1]). To block Notch signaling activation, we used several
gamma-secretase inhibitors (GSIs) and evaluate the inhibitory poten-
tial of GSIs on osteoclastogenesis. We measured the effect of GSIs on
osteoclastogenesis and normal spreading of osteoclasts by using the
mouse bone marrow-derived macrophages (BMMs) which may con-
tributes to insight of physiological relevant of in vivo. This data article
suggests valuable approach to GSIs treatment doses and potential of
those in the osteoclast differentiation and spreading.
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
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ject areaDevelopmental biologyype of data Figure, Graph
ow data was
acquiredCell culture, TRAP-stain, Microscope, OsteoMeasure XP program (version
1.01; OsteoMetrics).ata format Analyzed
xperimental
factorsBone marrow cells were obtained by ﬂushing tibiae of mice and nonadherent
cells were expanded for three days using M-CSF to generate Bone marrow-
derived macrophage, a progenitor of osteoclast.xperimental
featuresBone marrow-derived macrophages were differentiated osteoclast with
various dose and several gamma-secretase inhibitors in the presence of M-
CSF and RANKL. Fully differentiated osteoclasts were TRAP-stained to mea-
sure osteoclast number and spreading.ata source
locationSeoul National University, Seoul, Republic of Koreaata accessibility Data with this articleDValue of the data This data shows the effect of gamma-secretase inhibitors (GSIs) on osteoclast formation and
normal spreading.
 Various doses of GSIs provide comparison of inhibitory potential on osteoclast differentiation and
spreading.
 This data provides starting and target doses for several GSIs against osteoclast differentiation and
spreading that offers valuable approach for investigation of Notch signaling and gamma-secretase
involvement in osteoclast differentiation and cytoskeletal organization.1. Data
This data provides supporting information of the role of Notch signaling on osteoclast differ-
entiation and function [1]. Notch signaling has been shown to regulate osteoclastogenesis negatively
by Notch1 or positively by Notch2 [2]. To investigate whether Notch signaling affects osteoclast dif-
ferentiation and spreading, we assessed the inhibitory potential of four GSIs from BMM to mature
osteoclast forming period.2. Experimental design, materials and methods
2.1. Reagents
Recombinant human M-CSF and RANKL were purchased from PeproTech EC (London, UK). The
gamma-secretase inhibitors, Dibenzazepin (PubChem CID: 11454028), L685,458 (PubChem CID:
5479543), Compound E (PubChem CID: 11306390) DAPT (PubChem CID:5311272) were purchased
from Calbiochem-Merck Co (Darmstadt, Germany).
2.2. Cell culture
To obtain BMMs, bone marrow cells (BMCs) were collected by ﬂushing tibiae from 5-week-old
male ICR mice and red blood cells had been removed with ACK buffer (0.01 mM EDTA, 0.011 M
Fig. 1. GSIs inhibit osteoclast differentiation and spreading. (A–C) BMMs were cultured with DMSO or the indicated dose of
several GSIs in the presence of M-CSF (60 ng/ml) and RANKL (100 ng/ml) for 4 days. (A) After culturing, the cells were stained
for TRAP. Scale bar is 100 μm. (B) Osteoclasts that contained three or more nuclei were counted (left) and the number of
spreading osteoclasts was measured (right) (nPo0.05).
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cultured for three days in the presence of M-CSF (60 ng/ml) alone to generate BMM as previously
described [3].
To generate osteoclast, BMMs (4104 cells/well) were cultured in α-minimum essential medium
(α-MEM) containing 10% (v/v) heat inactivated fetal bovine serum (FBS), 50 U/ml penicillin, and
50 μg/ml streptomycin on 48-well culture plates in the presence of M-CSF (60 ng/ml) and RANKL
(100 ng/ml) for 4 days. The complete medium was changed every 3 days.
2.3. TRAP stain and measurement
Appeared osteoclasts were washed by PBS and ﬁxed by 3.7% formalin for 20 min. Then, ﬁxed cells
were stained for tartrate-resistant acid phosphatase (TRAP) by using the Leukocyte Acid Phosphatase
Assay kit (Sigma-Aldrich) following the manufacturer's procedure (Fig. 1A). DMSO- or several GSIs-
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and the number of spreading osteoclasts was measured by using the OsteoMeasure XP program
(version 1.01; OsteoMetrics) (Fig. 1B).
2.4. Statistical analysis
All quantitative data are represented as means7SDs (nZ3). Each experiment was performed 3–5
times, and the results from 1 representative experiment are shown. Statistical differences were
analysed by Student's t-tests. A value of Po0.05 was considered statistically signiﬁcant.Acknowledgments
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